z-logo
open-access-imgOpen Access
Mesenchymal Hamartoma of the Liver and DICER1 Syndrome
Author(s) -
María Apellániz-Ruiz,
Maria Segni,
Matthias Kettwig,
S. Glüer,
Dylan Pelletier,
Văn Hùng Nguyễn,
Rabea Wagener,
Cristina López,
Karl Muchantef,
Dorothée BouronDal Soglio,
Nelly Sabbaghian,
Mona K. Wu,
Stefano Zannella,
Marc R. Fabian,
Reiner Siebert,
Jan Menke,
John R. Priest,
William D. Foulkes
Publication year - 2019
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1812169
Subject(s) - medicine , mesenchymal stem cell , hamartoma , pathology , dermatology
Mesenchymal hamartoma of the liver (MHL) is a benign tumor affecting children that is characterized by a primitive myxoid stroma with cystically dilated bile ducts. Alterations involving chromosome 19q13 are a recurrent underlying cause of MHL; these alterations activate the chromosome 19 microRNA cluster (C19MC). Other cases remain unexplained. We describe two children with MHLs that harbored germline DICER1 pathogenic variants. Analysis of tumor tissue from one of the children revealed two DICER1 "hits." Mutations in DICER1 dysregulate microRNAs, mimicking the effect of the activation of C19MC. Our data suggest that MHL is a new phenotype of DICER1 syndrome. (Funded by the Canadian Institutes of Health Research and others.).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom